Drug approvals

Biocon Biologics gains USFDA approval for Kirsty, Interchangeable Rapid-Acting Insulin Aspart

Read more

AstraZeneca gains CDSCO approval for treatment of muscle-invasive bladder cancer

Read more

Biocon Biologics gains UK approval for Vevzuo and Evfraxy, Denosumab Biosimilars

Read more

EU approves Biocon Biologics’ Denosumab biosimilars

Read more

AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country

Read more

First-in-human trial for regenerative cell therapy for sensorineural hearing loss approved

Read more

Lupin gains USFDA approval for Loteprednol Etabonate Ophthalmic Gel

Read more

Alembic Pharmaceuticals receives US FDA approval for Doxorubicin Hydrochloride Liposome injection

Read more

Lupin launches Prucalopride Tablets in the US market post FDA approval

Read more

Lupin receives approval from US FDA for Prucalopride Tablets

Read more